e-learning
resources
Madrid 2019
Wednesday, 02.10.2019
Tuberculosis: treatment and management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Frequency of relapse rates in rifampicin-resistant tuberculosis in operated patients.
T. Bagdasaryan (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation)
Source:
International Congress 2019 – Tuberculosis: treatment and management
Session:
Tuberculosis: treatment and management
Session type:
Poster Discussion
Number:
5276
Disease area:
Respiratory infections, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Bagdasaryan (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation). Frequency of relapse rates in rifampicin-resistant tuberculosis in operated patients.. 5276
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Recurrence after successful treatment among patients with multidrug-resistant tuberculosis
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011
Prevalence of MDR and XDR tuberculosis among patients with failure of re-treatment course
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment
Source: Eur Respir J 2003; 21: 478-482
Year: 2003
The characteristics of previous tuberculosis treatment programmes in patients with tuberculosis relapses
Source: Eur Respir J 2001; 18: Suppl. 33, 473s
Year: 2001
Evaluation of relapse and defaulter pulmonary tuberculosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 647s
Year: 2005
Shorter treatment duration for selected patients with multidrug-resistant tuberculosis
Source: Eur Respir J 2011; 37: 227-230
Year: 2011
Reevaluation of treatment outcome of relapse and defaulter pulmonary tuberculosis cases
Source: Eur Respir J 2004; 24: Suppl. 48, 650s
Year: 2004
Predictors of treatment outcome in multidrug-resistant tuberculosis
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011
Timing of relapse of tuberculosis in people with co-infection (HIV/TB)
Source: Virtual Congress 2020 – Tuberculosis and comorbidities
Year: 2020
Predictors of treatment outcome in multidrug-resistant tuberculosis in Portugal
Source: Eur Respir J 2013; 42: 1747-1749
Year: 2013
The incidence of multi drug resistant tuberculosis among patients receiving standardized treatment regimen for suspected MDR-TB
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012
Management of multidrug-resistant tuberculosis and patients in retreatment
Source: Eur Respir J 2005; 25: 928-936
Year: 2005
Duration of hospitalization of patients treated for tuberculosis
Source: Annual Congress 2010 - Global tuberculosis control
Year: 2010
Multi-drug resistant tuberculosis: a retrospective analysis of cases over 10 years in a low incidence setting
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007
A multicentric cohort analysis of culture conversion and reversion in multidrug resistant tuberculosis (MDRTB) patients
Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights
Year: 2013
Treatment outcomes of extensively-drug resistant tuberculosis (XDR-TB) patients in 20 countries
Source: Annual Congress 2012 - Pros and cons of MDR- and XDR-TB treatment
Year: 2012
Detection of NTM in surgery samples from patients hospitalized with presumed TB
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019
Analysis of loss to follow-up in 4099 multidrug-resistant pulmonary tuberculosis patients
Source: Eur Respir J, 54 (1) 1800353; 10.1183/13993003.00353-2018
Year: 2019
Treatment effectiveness among newly detected patients with polyresistant tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 651s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept